Potential mechanisms of calcium dependent regulation of the mammalian cell cycle revealed by comprehensive unbiased label-free nLC-MS/MS quantitative proteomics by Kwasnik, Anna et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potential mechanisms of calcium dependent regulation of the
mammalian cell cycle revealed by comprehensive unbiased
label-free nLC-MS/MS quantitative proteomics
Citation for published version:
Kwasnik, A, Von Kriegsheim, A, Irving, A & Pennington, SR 2017, 'Potential mechanisms of calcium
dependent regulation of the mammalian cell cycle revealed by comprehensive unbiased label-free nLC-
MS/MS quantitative proteomics', Journal of proteomics. https://doi.org/10.1016/j.jprot.2017.08.006
Digital Object Identifier (DOI):
10.1016/j.jprot.2017.08.006
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of proteomics
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
Accepted Manuscript
Potential mechanisms of calcium dependent regulation of the
mammalian cell cycle revealed by comprehensive unbiased label-
free nLC-MS/MS quantitative proteomics
Anna Kwasnik, Alex von Kriegsheim, Andrew Irving, Stephen R.
Pennington
PII: S1874-3919(17)30269-5
DOI: doi: 10.1016/j.jprot.2017.08.006
Reference: JPROT 2917
To appear in: Journal of Proteomics
Received date: 21 November 2016
Revised date: 3 August 2017
Accepted date: 5 August 2017
Please cite this article as: Anna Kwasnik, Alex von Kriegsheim, Andrew Irving, Stephen
R. Pennington , Potential mechanisms of calcium dependent regulation of the mammalian
cell cycle revealed by comprehensive unbiased label-free nLC-MS/MS quantitative
proteomics, Journal of Proteomics (2017), doi: 10.1016/j.jprot.2017.08.006
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
1 
 
 
Potential mechanisms of calcium dependent regulation of the mammalian cell cycle 
revealed by comprehensive unbiased label-free nLC-MS/MS quantitative proteomics 
 
Anna Kwasnik1, Alex von Kriegsheim1,2,3, Andrew Irving4, Stephen R Pennington*1 
Highlights: 
 Global proteomic effect of Ca2+ influx inhibition on G1 phase was examined  
 A total 182 differentially expressed proteins were identified with diverse functions 
 Cell proliferation, cell morphology, and cellular assembly and organisation were 
altered by the inhibition of Ca2+ influx. 
 Potential mechanism of Ca2+ dependent regulation of cell cycle was proposed  
 Selected protein expression changes and biological processes were validated. 
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Abstract 
Calcium (Ca2+) controls progression through the mammalian cell cycle by engaging a diverse 
range of molecular pathways. While the essential role of spatio-temporal Ca2+ signaling in 
the cell cycle is well established, the precise mechanisms by which it regulates cell cycle 
entry and progression through G1 are not particularly well understood.  
Here, high-resolution label-free semi-quantitative nLC-MS/MS analysis has been used to 
support a highly reproducible unbiased analysis of Ca2+ influx dependent growth factor 
induced protein expression early in G1 in human fibroblasts. Using this strategy a panel of 
182 proteins whose expression was Ca2+ dependent were identified. Pathway analysis has 
indicated that Ca2+ likely regulates cell proliferation via PI3K/AKT pathway and its 
downstream target mTOR. In addition to cell proliferation found proteins were involved in 
the regulation of cell morphology and cellular assembly and organization, the environmental 
clues, which are known to regulate G1 progression. 
Reported here data represents one of the most comprehensive proteomic datasets of 
growth factor and Ca2+ dependent protein expression in the mammalian cell cycle and 
provides a rich source of publically available data to support continued investigation of the 
role of Ca2+ in G1 progression at both the molecular and systems level.  
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Introduction 
Cell division is essential for the growth, maintenance and reproduction of all mammalian 
organisms [1,2]. A detailed knowledge of the biochemical events that regulate the complex 
temporal sequence of events, which comprises the cell division is therefore central to 
understanding both normal physiology and disease. Notably, cancer is accompanied by 
aberrant regulation of the cell division cycle [3] and identification of the key regulatory 
biochemical events in this process provides an opportunity to develop strategies for cancer 
therapy [4,5]. 
Evidence from a number of studies, has shown that capacitive calcium entry (CCE) - also 
called store operated calcium entry (SOCE) - plays a fundamental role in cell cycle initiation 
and progression through the cell cycle in non-excitable cells including fibroblasts [6–8]. It is 
recognised that the transient increase in cytoplasmic levels of Ca2+ following growth factor 
stimulation of cells acts as a mitogenic signal contributing to the initiation of the G0/G1 
transition, regulation of G1 progression and subsequent entry into S phase [9]. The 
mechanism of capacitive Ca2+ entry (CCE), in which inositol (1,4,5) trisphosphate activated 
release of Ca2+ from internal ER stores triggers the entry of Ca2+ from outside the cell, was 
first proposed by Putney in 1986 [10]. For many years the key components involved in this 
coupling between store release and Ca2+ entry were unknown but the role of Ca2+ entry was 
investigated with some success by use of several inhibitors of CCE. Among these inhibitors is 
the imidazole derivative SK&F96365 and a range of reports have shown that it efficiently 
and reversibly blocks Ca2+ influx [7,11], and inhibits the proliferation of multiple cell lines 
[7,12–15]. Growth factors and mitogens evoke typical biphasic changes in cytoplasmic Ca2+ 
levels. Initially there is a rapid transient rise contributed by the releasing of Ca2+ from 
internal ER stores and this is followed by a sustained elevated plateau during G1 phase 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
5 
 
contributed by Ca2+ influx from external stores [9,16]. In the absence of extracellular Ca2+ or 
when Ca2+ influx is blocked (including by SK&F96365), mitogens evoke a transient elevation 
of Ca2+ but do not show the subsequent sustained plateau of elevated Ca2+ or progression to 
S phase [16]. In fibroblasts, the sustained plateau is mediated by Ca2+ influx, which is 
regulated by CCE. Together these observations reveal that CCE mediated Ca2+ influx is 
necessary for Ca2+ dependent regulation of the G1 phase events that occur during the 
plateau phase and ultimately are required for progression to S phase. The discovery of two 
critical molecular components of CCE - STIM [17] and Orai [18] proteins – has provided 
additional evidence that Ca2+ influx is necessary for the proliferation of both normal and 
cancer cell lines [19–22]. 
Despite the role of Ca2+ in regulation of the cell cycle being well established and there being 
much known about the biochemical events that regulate G1 phase progression, the 
molecular mechanism(s) by which Ca2+ signalling regulates these G1 biochemical events is 
poorly characterised [23,24]. Notably, when quiescent cells (in G0) are exposed to growth 
factors and mitogens a series of intracellular signalling events are initiated to control entry 
into and progression through G1 phase. These signals include the activation of receptor 
tyrosine kinases (RTK) and engagement of multiple signalling pathways, including the 
mitogen-activated protein kinase (MAPK) pathway. Importantly, Katoch et al. have shown 
that the activity of ERK1/ERK2 - components of the MAPK pathway - is Ca2+ dependent [25]. 
The downstream targets of the mitogen signalling pathways and the key proteins that 
regulate G1 progression are cyclin dependent kinases (CDK; CDK4/6 and CDK2) and cyclins D 
and E [26]. The expression of D and E type cyclins is positively regulated by ERK1/ERK2 
through the regulation of transcription factors such as NF-B, AP-1, STAT or CREB. 
Importantly it has been shown that Ca2+ dependent regulation of ERK1/ERK2 inhibits cyclin 
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D1 transcription through NF-B [27]. There is also indication that Ca2+ is important for the 
expression of the immediate-early genes including FOS, JUN and MYC [28–30]. 
Evidence from multiple studies directly (deletion of components of CCE, STIM and ORAI) or 
indirectly (blocking with specific inhibitors) targeting CCE, have confirmed that Ca2+ controls 
the transition of cells through the R point by regulating the expression and function of key 
G1 phase regulatory proteins such as CDK and their associated activating cyclins and cyclin 
dependent kinases inhibitors [30–32]. Furthermore, Ca2+ is required for retinoblastoma (Rb) 
phosphorylation [28,30,33]. 
In an early study to investigate the effect of Ca2+ influx on gene and protein expression 
induced by growth factor we showed that treatment of murine fibroblasts with SK&F96365 
regulated multiple genes at the both transcript and protein level [12]. Here, we used 
biological replicate, rigorous sample preparation and high resolution mass spectrometry to 
establish at a comprehensive level the extent to which growth factor induced changes in 
protein expression are dependent on Ca2+ influx. Out of 4,411 proteins identified by nLC-
MS/MS analysis across all conditions, the expression of 182 proteins was influenced by 
inhibition of Ca2+ influx. We have used pathway analysis to attempt to reveal which of these 
Ca2+ sensitive proteins may regulate cell proliferation. Notably, we have identified a panel of 
proteins including ACP1, CDC42, EGFR, F2R, ERBB4, HRAS, IKBKB, PIK3R1, PAX and RHOB. 
that are known to be involved in both cell proliferation and cell morphology (which is 
influenced by Ca2+ influx). These proteins represent key targets for further mechanistic 
studies to investigate how Ca2+ signalling and the regulation of cell shape may control the 
progression of mammalian cells through G1 to S phase including via one mechanism 
proposed here. 
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EXPERIMENTAL SECTION 
Cell Culture 
Human MRC-5 cells were grown in MEM (Minimum Essential Medium Eagle (MEM; Sigma-
Aldrich) supplemented with 10 mM L-glutamine, 5 mM sodium pyruvate, MEM non-
essential amino acid solution (Sigma-Aldrich) and 1 % penicillin/streptomycin (Life 
Technologies, Gibco) hereafter referred to as 'full MEM' to which was added 10 % FBS 
(HyClone). Cells were maintained in humidified atmosphere of 5 % CO2 at 37 °C and 
regularly sub-cultured with 0.25 % Trypsin – EDTA (Life Technologies, Gibco) by standard 
procedures.  
Generation of quiescent, synchronised MRC-5 cells  
Exponentially growing MRC-5 cells were sub-cultured into 6-well plates at 5 x 105 cells per 
well and incubated overnight in full MEM containing 10 % FBS to allow cell attachment. Cells 
were then washed 3 times in full MEM containing 0.2 % FBS  and incubated for a further 24 
h in the same medium (full MEM containing 0.2 % FBS) to synchronise cells in G0/G1.  
Induction of cells to re-enter cell cycle 
To induce cell cycle re-entry MRC-5 cells, were stimulated with either 10 % FBS MEM 
medium or MEM medium supplemented with a defined mixture of growth factors: 10 ng/ml 
EGF (PeproTech), 50 ng/ml dexamethasone (Sigma-Aldrich), 5 µg/ml apo-Transferrin (Sigma-
Aldrich), 5 µg/ml insulin (Sigma-Aldrich) and 0.5 % albumin from bovine serum (Sigma-
Aldrich), as described previously [34,35]. 
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Cell treatment with Ca2+ influx inhibitor SK&F96365 
A stock of 10 mM SK&F96365 (Santa Cruz Biotechnology) was prepared by dissolving 
SK&F96365 in DMSO (Sigma-Aldrich) and stored at -20 °C. The final concentrations of 
SK&F96365 used in experiments were prepared by diluting SK&F96365 stock in a medium 
that was used in experiments. Quiescent cells were incubated with SK&F96365 alone for 15 
min prior to stimulation of cells with FBS or mixture of growth factors. 
Live cell Ca2+ measurement 
Cytosolic Ca2+ levels were estimated in live cells by the measurement of the fluorescent 
emission of Ca2+ indicator Fura-2 at two excitation maxima, 380 nm for Ca2+ unbound and 
340 nm for Ca2+ bound form of Fura-2 [36]. MRC-5 cells for these experiments were seeded 
on 9 mm round glass cover slips that were placed in the wells of 24 well plates. Cells were 
seeded at 60,000 cells per well and incubated in full MEM medium containing 0.2 % FBS for 
24 h. A stock of Fura-2 (Thermo Fisher Scientific) was dissolved in DMSO at concentration of 
2 mM. The final, 6 µM concentration of Fura-2 was prepared by diluting Fura-2 stock in Ca2+ 
recording buffer (125 mM NaCl (Sigma-Aldrich), 2 mM MgCl2 (Calbiochem®), 4.5 mM KCl 
(Fluka), 10 mM Glucose (Gibco®), 2 mM CaCl2 (Sigma-Aldrich) and 20 mM HEPES (Sigma-
Aldrich) at pH 7.4 in presence of 0.2 % FBS). 3 µl of Fura-2 stock was re-suspended in 1 ml of 
Ca2+ recording buffer by sonication. Glass cover slips with quiescent MRC-5 cells were 
transferred to 35 x 10 mm EASY GRIP tissue culture dishes, washed 3 times with calcium 
recording buffer and then 1 ml of 6 µM Fura-2 solution was added. Cells were loaded with 
Fura-2 for an hour at RT protected from light. Cells were then washed three times in Ca2+ 
recording buffer and left in the same buffer for additional 20 min at RT protected from light. 
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Fura-2 loaded cells were incubated in 20 µM of SK&F96365 for an hour in Ca2+ recording 
buffer prior to Ca2+ imaging to stabilise cytoplasmic Ca2+ levels. Images were captured using 
a microscope equipped with 60X water-immersion objective and a 12-bit cooled CCD 
camera and capturing board (Sensicam, PCO, Germany) as described previously [37]. For 
excitation of Fura-2 at 340/380 nm a PolyChrome IV monochromator (Till Photonics, 
Germany) was used. To avoid bleaching of Fura-2 the monochromator was attenuated with 
neutral density filters. Detected light signals were transmitted to the computer and 
recorded by MetaFluor Fluorescence Ratio Imaging Software (Molecular Devices, LLC; USA). 
The excitation of Fura-2 was recorded in a time dependent manner and the images were 
acquired in a fast mode using 2×2 binning with a temporal resolution of ~100 mseconds per 
frame. Recorded Ca2+ images were analysed with MetaFluor software. Individual cells were 
selected by drawing a region of interest (ROI) around the cell and the Fura-2 ratio 340/380 
was recorded and saved as numerical values. Each value was normalised by subtracting 
background noise from a cell free region. Numerical values were then exported to OrginPro 
8 SR0 software (version 8.0724). Data from individual cells was plotted separately as traces 
and as an average of all cells analysed on one glass cover slip as a linear function of time 
versus Fura-2 ratio of the two fluorescent excitation wavelengths for bound and unbound 
Fura-2. Due to the difference in Fura-2 loading between different experimental conditions 
the data from control and SK&F96365 treated cells were compared by normalising data to 
the same values.  
Measurement of cell proliferation  
Proliferation of MRC-5 cells was monitored using carboxyfluorescein succinimidyl ester 
(CFSE), a dye that covalently binds to all free amines on the surface and inside the cell. Cell 
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proliferation is monitored by flow cytometry via monitoring of the fluorescent intensity of 
the CFSE over the period of time. A stock of CFSE (Thermo Fisher Scientific) was dissolved in 
DMSO at concentration of 5 mM. The final, 5 µM concentration of CFSE was prepared by 
diluting CFSE stock in phosphate buffered saline (PBS; OXOID). Quiescent MRC-5 cells were 
washed 3 times with PBS and then 1 ml of 5 µM CFSE solution was added to each well and 
cells were incubated with CFSE for 20 min at humidified atmosphere of 5 % CO2 at 37 °C 
covered with tin foil to protect from light. The CFSE staining solution was removed by 
aspiration and cells were washed twice in 1 % solution of albumin from bovine serum in PBS 
and twice in full MEM medium containing 0.2 % FBS. CFSE loaded cells were left overnight in 
0.2 % FBS MEM medium. Cells were then stimulated to enter cell cycle with 10 % FBS or 
mixture of growth factors in the presence or absence of SK&F96365. 48 h after stimulation, 
cells were harvested by trypsinisation and washed once with ice-cold PBS by centrifugation 
for 5 min at 1,200 rpm at 4 °C. Cell pellets were then resuspended in 100 µl of PBS and 
analysed on an Accuri C6 flow cytometer (Becton, Dickinson and Company). The mean 
intensity of the CFSE dye was quantified using FCS 4 Express Flow Cytometry software, 
version 4.07.0020. All samples were analysed as biological triplicates. 
Cell cycle analysis 
Cells were harvested by trypsinisation and washed twice with PBS at 4 °C. Cells were fixed 
with ice cold 70 % ethanol, pelleted by centrifugation and washed twice with PBS at 4 °C. 
Cells were then treated with RNase A (20 µg/ml; Sigma-Aldrich) and incubated with 40 
µg/ml of propidium iodide (Sigma-Aldrich) for 30 min and then analysed on an Accuri C6 
flow cytometer (Becton, Dickinson and Company). DNA content was quantified using FCS 4 
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Express Flow Cytometry software, version 4.07.0020. All samples were analysed as 
biological triplicates.   
Sample preparation for nLC-MS/MS 
Samples were prepared according to the filter aided sample preparation (FASP) method as 
described by Wiśniewski et al. [38] . Briefly, adherent cells were washed twice with ice-cold 
PBS and then lysed by sonication in SDS lysis buffer (0.2 % (v/v) SDS in 0.1 M Tris/HCl, pH 
7.6). Samples were heated at 95 °C for 5 min and after centrifugation of cell debris; the 
supernatants were assayed for protein concentration (BCA assay kit (Pierce)). Subsequently 
cell lysate proteins (100 µg in 100 µl) were reduced with DTT (final concentration of 0.1 M), 
combined with 200 µl of UA buffer (8 M urea in 0.1 M Tris/HCl, pH 8.5), loaded onto 30,000 
MWCO Vivacon 500 spin membranes (Sartorius) and centrifuged at 14,000 g for 40 min. 
Spin filter membranes were subsequently washed with UA buffer and then bound proteins 
were alkylated with final concentration of 0.05 M iodoacetamide. Spin Filter membranes 
were then washed three times in UB buffer (8 M urea in 0.1 M Tris/HCl, pH 8.0). Proteins on 
the spin filters were subsequently digested with Lys-C and trypsin. Initially proteins were 
digested overnight with Lys-C (enzyme: substrate 1:50) and then for additional 3 h with 
trypsin (enzyme: substrate 1:100). Both digestions were performed at 37 °C. Digestion was 
stopped by the acidification of samples to a final concentration of 1 % TFA. The final 
concentration of peptides was estimated (NanoDrop readings at 280 nm) and prior to mass 
spectrometry analysis, peptides were desalted and purified with in house prepared stage tip 
[39,40]. Briefly, stage tips were activated by washing with 50 % ACN 0.1 % TFA prior to 
addition of peptides in aqueous 1 % TFA. The stage tips were then washed twice with 1 % 
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TFA and peptides were eluted with 50 % ACN, 0.1 % TFA and then dried by evaporation 
(speed vacuum).  
nLC-MS/MS 
Samples were analysed by nano-flow reverse phase LC using a Q-Exactive mass 
spectrometer connected online to an Ultimate Ultra3000 chromatography system (both 
Thermo Fisher Scientific) as described [41]. Briefly, dried peptides were reconstituted in 0.1 
% TFA and 2 µg of each sample were loaded on in house prepared analytical column (150 
mm length, 75 µm inside diameter) packed in house with 1.9 µm ReprosilAQ C18 (Dr Maisch 
GmbH). Tryptic peptides were separated using a 130 minute linear gradient from 4 % to 32 
% acetonitrile at a flow rate of 250 nl/min. The mass spectrometer was operated in data-
dependent acquisition mode with a top-12 MS/MS scanning approach. For protein label-
free identification and quantification, tandem mass spectra and peptide fragments of the 12 
most abundant peaks were acquired in the linear ion trap by peptide fragmentation using 
higher energy collisional dissociation (HID). A 2300 V potential was applied to column with a 
capillary temperature of 320 °C. Each biological sample was analysed as a technical 
duplicate. Experiments were repeated a minimum of three times. 
Data processing and analysis 
MS and MS/MS data were processed using MaxQuant computational proteomics platform 
[42,43] version 1.4.1.2. Peak lists, generated in MaxQuant were searched using Andromeda 
[44] peptide search engine against the UniProt database (release 2013_12, taxonomy Homo 
Sapiens) containing 39,648 protein entries supplemented with frequently observed 
contaminants and containing forward and reverse sequences. Multiplicity was set to one 
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and trypsin specified with up to two missed cleavages. Carbamidomethylation of cysteines 
was defined as a static modification, oxidation of methionine and protein N-terminal 
acetylation were set as variable modifications. Minimum peptide length of 7 was set and 6 
ppm and 20 ppm was used for fragmented and precursor mass tolerances respectively. A 
retention time tolerance of 1 min was used to align any time shift in acquisition between 
samples. False discovery rates (FDR) at both peptide and protein levels were set at 1 %. 
Protein identification was performed with at least one unique peptide.  
Bioinformatics analysis was performed with Perseus software. Variability between biological 
(n=3) and technical (n=2) replicates is reported as Pearson and r2 correlations as log2 values. 
Data for analysis was transformed to a log2 scale and missing values were imputed with 
constant values to allow the assignment of the presence or absence of proteins between 
conditions. All statistical Student’s t-tests, to distinguish proteins differentially expressed 
between conditions, were performed with a p-value threshold of 0.05. For hierarchical 
clustering, Euclidean distances were applied using logarithmised intensities after z-score 
normalisation of the statistically significant data. Principal component analysis was 
undertaken on logarithmised values only.  
Differentially expressed proteins were further analysed using Ingenuity Pathway Analysis 
Knowledge Database (Ingenuity Systems) to map statistically significant proteins to the 
pathways and biological processes in which they were enriched. 
Sample Preparation for Immunoblotting 
Cells were washed twice with ice-cold PBS and then lysed in RIPA buffer (Thermo Fisher 
Scientific) in the presence of protease (0.5 % v/v final concentration; Sigma-Aldrich) and 
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phosphatase inhibitors (1 % v/v final concentration; Sigma-Aldrich). Cell lysates were then 
transferred to Eppendorf tubes and incubated for 15 min on ice. Following this, samples 
were centrifuged at 18,000 g for 20 min at 4 °C and supernatants were transferred to new 
Eppendorf tubes. 
Total protein concentration was determined using the BCA assay according to the 
manufacturer's instructions (Pierce). For each sample, 20 µg of total protein (in 10 µl RIPA 
buffer) was mixed with 10 µl of SDS sample buffer (400 mM Tris-HCl [pH 6.8], 30 % glycerol, 
10 % SDS, 0.2 M DTT, 0.02 % Coomassie blue G-250) and samples were denatured by 
heating at 95 °C for 5 min. 
Immunoblotting 
Protein samples were separated by SDS-PAGE using in house made 10 or 12 % 
polyacrylamide gels run on Mini-PROTEAN® Tetra Handcast Systems (Bio-Rad). Denatured 
samples (20 µg total protein) were loaded into the wells of 4 % stacking gels using a 
micropipette. Electrophoresis of gels was undertaken at 100 V (constant voltage) using 
0.025 M Tris, 0.192 M glycine and 1 % SDS running buffer. To determine the relative 
molecular weight of immunoblotted proteins, Precision Plus Protein dual colour marker 
(Bio-Rad) was loaded onto each gel.  
Electrophoretically separated proteins were transferred onto PVDF transfer membranes 
(PerkinElmer), pre-soaked in 100 % methanol using a wet mini-transfer apparatus (Bio-Rad). 
The filter paper, sandwiching padding and gels were pre-soaked in transfer buffer (0.025 M 
Tris, 0.192 M glycine and 20 % methanol) prior to electrophoretic transfer that was carried 
out on ice, in transfer buffer at 100 V (constant voltage) for 145 minutes. The efficiency of 
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electrophoretic transfer was verified by staining immobilised proteins on PVDF membranes 
with Ponceau S solution (0.1 % Ponceau S, 5 % acetic acid; Sigma-Aldrich) by standard 
procedure. 
Subsequently, PVDF membranes were incubated overnight at 4 °C in blocking buffer 
containing 5 % bovine serum albumin (BSA; Sigma-Aldrich), 0.05 % Triton 100 in PBS. 
Blocked membranes were incubated overnight at 4°C with primary antibodies diluted 
1:1000 in blocking buffer. Membranes were then washed 5 times for 5 minutes each in 
washing buffer (0.05 % Triton 100 in PBS; PBS-T) and incubated for 45 minutes at room 
temperature with the corresponding horseradish peroxidase (HRP) conjugated secondary 
antibodies (1:1000 in PBS-T containing 5 % non-fat milk (Sigma-Aldrich)). Membranes were 
then washed 5 times for 5 minutes each in PBS-T and then incubated in ECL Western 
Blotting Substrate (Medical Supply) and further visualised on Fuji medical X-Ray films 
(Fujifilm Global) to detect signal. 
Primary antibodies used for immunoblot analysis were paxillin (#610620; Becton, Dickinson 
and Company), GAPDH (#2118; Cell Signaling Technology), RAS (#OP40; Calbiochem), CDC42 
(#sc-87; Santa Cruz Biotechnology). Secondary antibodies were horse anti-mouse IgG (heavy 
and light chain) HRP conjugated (#7076; Cell Signaling Technology) and goat anti-rabbit IgG 
(heavy and light chain) HRP conjugated (#7074; Cell Signaling Technology). 
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RESULTS  
Effect of SK&F96365 on growth factors regulated cytoplasmic levels of Ca2+ and cell 
division - The selective inhibitor of store-operated Ca2+ influx, SK&F96365 [11,15] inhibits 
the proliferation of a variety of cell types [12–15] but its effect on human non-transformed 
MRC-5 fibroblast cells line has not been investigated to date. Thus, initial experiments were 
performed to establish the effect of SK&F96365 on cytoplasmic Ca2+ levels and proliferation 
in MRC5 cells. Measurement of Fura-2 fluorescence revealed a typical biphasic elevation of 
the cytoplasmic [Ca2+] when quiescent MRC-5 fibroblasts were stimulated with FBS. An 
initial peak of cytoplasmic [Ca2+] was followed by an elevated plateau (Fig 1A). However, 
when quiescent cells were stimulated with FBS in the presence of SK&F96365, although the 
initial peak of cytoplasmic [Ca2+] was similar to that observed when cells were stimulated 
with FBS alone, the subsequent plateau of [Ca2+] was much lower. These data are consistent 
with inhibition of Ca2+ influx by SK&F96365, which has been observed in several other cell 
lines.  
Insert Figure 1 here 
To investigate the effect of SK&F96365 on the proliferation of MRC-5 cells and progression 
through the cell cycle, cellular DNA content was measured by flow cytometry. Comparison 
analysis between quiescent cells and cell stimulated with FBS showed a statistically 
significant decrease in the percentage of cells in G0/G1 (from 91.0 % to 50.8 %) and a 
statistically significant increase in the percentage of the cells in S phase (from 1.7 % to 46.2 
%). No difference in the percentage of cells in G2/M between quiescent cells and cells 
stimulated with FBS was observed. Similar observations were made when comparing cells 
stimulated with FBS in the absence and presence of SK&F96365. A statistically significant 
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decrease in the percentage of cells in G0/G1 (from 83.6 % to 50.8 %) and a statistically 
significant increase of the percentage of cells in S phase (from 5.2 % to 46.2 %) was 
observed in cells stimulated with FBS alone when compared to the cells incubated with FBS 
in the presence of SK&F96365. As expected no difference in the percentage of cells in G0/G1, 
S and G2/M was observed when comparing quiescent cells to cells stimulated with FBS in 
the presence of SK&F96365 (Fig 1B). The decreased percentage of cells in G0/G1 and 
increased percentage of cells in S phase 20 h after stimulation with FBS may suggest that 
cells have entered the cell cycle. A similar percentage of cells in G0/G1, S and G2/M between 
quiescent cells and cells stimulated with FBS in the presence of SK&F96365 may suggest that 
SK&F96365 at the concentration of 60 µM inhibits FBS induced cell proliferation by arresting 
cells in G0/G1. 
The effect of SK&F96365 was dose dependent, and the percentage of cells in G0/G1 rose 
gradually for concentrations ranging from 0 to 60 µM and subsequently persisted at a 
similar level for concentrations ranging 60 µM to 100 µM (Fig 1C). This suggests that at a 
concentration of 60 µM SK&F96365 reached its maximum effectiveness on MRC-5 cells and 
that further increasing the concentration of SK&F96365 had no effect on the percentage of 
cells in G0/G1. Based on these results 60 µM SK&F96365 was accepted as the most effective 
dose and used in subsequent experiments. 
To support the observation that SK&F96365 inhibits cell division, an analysis of cell 
proliferation was performed. Comparison of the CFSE fluorescent intensity of quiescent cells 
stimulated with FBS cells arrested in G0/G1 showed a statistically significant decrease in the 
CFSE intensity between quiescent cells and cells stimulated with FBS 48 h after stimulation. 
The intensity of CFSE of cells stimulated with FBS was 44 % lower than the CFSE intensity of 
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quiescent cells. Similar observation was made when comparing the CFSE intensity of cells 
stimulated with FBS in the absence and presence of SK&F96365. A statistically significant 
decrease in CFSE fluorescent intensity (40 %) was observed in cells treated with FBS in the 
presence of SK&F96365 when compared to the cells incubated in FBS alone. No difference 
in the CFSE fluorescent intensity between quiescent cells and cells stimulated with FBS in 
the presence of SK&F96365 was observed (Fig 1D). The decreased CFSE intensity of cells 
stimulated with a mixture of FBS when compared to the CFSE intensity of quiescent cells 
may suggest that cells have gone through cell division. The similar CFSE intensity observed 
for quiescent cells and cells stimulated with FBS in the presence of SK&F96365 may suggest 
that SK&F96365 blocked the FBS induced proliferation of the cells.  
Many pharmacological inhibitors show side effects and treatment of cells with chemical 
compounds can affect cell viability. Thus, to investigate if SK&F96365 at the concentration 
of 60 µM has a toxic effect on MRC-5 cells, the effect of SK&F96365 was evaluated by PI 
exclusion by live cells. Comparison analysis showed an increase from 1.7 % to 4.6 % in PI 
positive cells stimulated with growth factors in the presence of SK&F96365 when compared 
to cells stimulated with growth factors alone. A similar observation was made when 
comparing cells treated with FBS in the presence of SK&F96365 to the cells incubated with 
FBS alone. Treatment of cells with SK&F96365 increased the percentage of PI positive cells 
from 2.1 % to 4.5 %. An increased number of the PI positive cells in the presence of 
SK&F96365 may suggest that SK&F96365 has little toxic effect on MRC-5 cells 
(Supplementary Fig S-1). The observation of low toxic effects of SK&F96365 in the MRC-5 
cell line was further supported by assessment of the reversibility of cell treatment with 
SK&F96365. Treatment of cells with inhibitor induced cell rounding and retraction and this 
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effect of SK&F96365 on cell morphology was reversible as removing of inhibitor from the 
culture medium caused reversible changes towards fibroblast, spindle-like morphology 
(Supplementary Fig S-2). In addition to changes in cell morphology, the process of fibroblast 
migration was completely abolished in the presence of SK&F96365. The functional activity 
of the cells was fully recovered after removal of inhibitor from culture medium 
(Supplementary Fig S-3). 
Experimental strategy and workflow for global nLC-MS/MS analysis of Ca2+ regulated 
protein expression changes in G1 phase - Our data has shown that SK&F96365 efficiently 
reduces serum growth factors regulated cytoplasmic level of Ca2+ and that this reduction in 
the level of cytoplasmic Ca2+ is associated with an inhibition of cell proliferation by arresting 
cells in G0/G1 phase. Thus, we next sought to investigate the extent to which inhibition of 
Ca2+ signalling may influence the profile of growth factor induced protein expression early in 
G1 phase of the cell cycle by label-free nLC-MS/MS. For the nLC-MS/MS discovery 
experiment, MRC-5 cells were initially arrested in G0/G1 phase and then released from the 
arrest by stimulation with a defined mixture of growth factors containing EGF, 
dexamethasone, apo-transferrin, insulin and albumin from bovine serum to precisely 
control pathways that are activated upon re-stimulation to cell cycle entry. To investigate 
the effect of Ca2+ influx on protein expression changes, cells were stimulated in the absence 
and presence of SK&F96365. Treatment was stopped three hours after stimulation – this 
being the time close to the transition of cells from G0 to G1 phase. Sample preparation, 
acquisition and data analysis were carried out according to the workflow shown in Fig 2. In 
brief, samples for the nLC-MS/MS discovery experiment were lysed in SDS-based lysis 
buffer. Extracted proteins were then quantified using the BCA assay and equal amounts of 
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protein from each sample were digested with endoproteinase LysC and trypsin according to 
the FASP protocol [38]. To ensure that equivalent amounts of peptide material were loaded 
onto the Q-Exactive, peptides from the FASP digestion were quantified via NanoDrop. Next, 
peptides were desalted and purified on StageTips [39]. To achieve highly reliable results, the 
cell treatment and sample preparation for mass spectrometry analysis was performed on 
three independent days. Each biological sample was analysed as a technical replicate on the 
Q-Exactive in one combined run. The efficiency of cell treatment with the defined mixture of 
growth factors in the presence and absence of SK&F96365 was evaluated by flow cytometry 
each time the samples were prepared for mass spectrometry analysis. The quality of the raw 
data from the Q-Exactive analysis was visually inspected with XcaliburTM software and then 
data were imputed into MaxQuant software for feature identification and detection [42]. 
Statistical analysis of the data and further selection of statistically important proteins was 
performed with Perseus software. The panel of proteins that were selected by statistical 
analysis were next subjected to pathway analysis (IPA software) to map these proteins to 
pathways and biological processes in which selected proteins could play a role. The 
expression of three proteins selected by statistical analysis and found to be involved in cell 
cycle regulation was validated by Western blot analysis to corroborate findings from 
analysis of the nLC-MS/MS data.  
Insert Figure 2 here 
Proteomic analysis of Ca2+ regulated protein expression changes in G1 phase - In order to 
investigate the observed global protein expression changes in response to the inhibition of 
Ca2+ influx, label-free nLC-MS/MS analysis was performed. Effective interpretation of the 
comprehensive nLC-MS/MS proteomic data for the purpose of mechanistic insight requires 
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a robust and reproducible strategy to acquire this data. Thus, the first step in nLC-MS/MS 
data analysis was to establish the extent to which processes applied during this study were 
reproducible in order to further decide on the statistical threshold to be applied. Visual 
inspection of the raw MS data showed normal distribution of total ion chromatograms (TICs) 
and highly consistent TIC’s between technical (Fig 3A) and biological (Fig 3B) replicates. 
Moreover, comparison of the intensities (LFQ) of individual proteins revealed an average 
Pearson correlation of 0.99 for both technical (Fig 3C) and biological (Fig 3D) replicates, thus 
confirming good quantitative correlation of the data. Database searching of the MS/MS data 
(see Experimental Procedures) resulted in the identification of around 4,000 proteins in 
each individual cell lysate. Both technical replicates (n=2) and biological replicates (n=3) 
showed an average of 95 % overlap in proteins identified (see Fig 3E and Fig 3F). Detailed 
data showing the reproducibility between technical and biological replicates including 
qualitative analysis, TICs, correlation plots and overlap in protein identification can be found 
in Supplementary FigsS-4, S-5 and S-6. This data demonstrates that highly reproducible and 
comprehensive analysis of protein expression was obtained from analysis of total cell lysates 
of non-transformed primary human lung fibroblasts (MRC-5 cells). In these and subsequent 
experiments a total of 4,411 proteins were identified from MRC-5 cells across all conditions 
with high confidence (false discovery rate < 1 %; for details see Supplementary Table 1). 
Insert Figure 3 here 
To identify proteins that are regulated by the inhibition of Ca2+ influx, statistical analysis of 
the 4,411 identified proteins was performed. Of over 4,000 proteins measured, incubation 
of cells with growth factors in the presence of SK&F96365 (60 µm) had a significant effect on 
the expression of 182 proteins (Fig 4A and Table 1). Of the proteins changing in the presence 
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of SK&F96365, 71 were significantly up-regulated and 111 were significantly down-regulated 
(see Supplementary Table 2).  
Insert Table 1 here 
Furthermore, the comparison of protein expression levels for all proteins measured in cells 
treated with purified growth factors in the absence and presence of SK&F96365 showed a 
very strong overall negative correlation (Supplementary Fig S-7). This shows that, for the 
most part, changes in protein expression under both conditions follows an opposing trend in 
expression - proteins that are up-regulated with growth factors were down-regulated in 
cells incubated with growth factors in the presence of SK&F96365. Similarly, most of the 
proteins that were down-regulated in cells treated with growth factors were up-regulated in 
cells with inhibited Ca2+ influx. 
Insert Figure 4 here 
In order to identify proteins that may play a crucial role in Ca2+ dependent regulation of 
growth factor induced proteins in the G1 phase of the cell cycle, grouping of statistically 
significant proteins into hierarchical clusters and principle components was performed. 
Unsupervised hierarchical clustering of 291 proteins that were found to be differentially 
expressed between the four conditions used in these experiments resulted in clear grouping 
of the biological replicates and a clear distinction between the different conditions (Fig 4B). 
Fig 4B shows that the protein expression pattern of cells incubated with growth factors and 
treated with SK&F96365 (G+) were most closely related to the expression pattern observed 
in control (quiescent) cells (C). More importantly, some of the proteins whose expression is 
regulated by SK&F96365 are likely to play a role in growth factor induced G1 and cell cycle 
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progression. When analysing the expression profile of proteins between all four conditions, 
the most interesting were clusters where the protein expression profile was similar for the 
following conditions; control (quiescent) cells (C), control (quiescent) cells treated with 
SK&F96365 (C+) and cells incubated with growth factors and treated with SK&F96365 (G+) 
but the expression of these proteins was opposite in the cells incubated with growth factors 
(G). These clusters represent proteins that were not affected by the treatment of quiescent 
cells with SK&F96365, the growth factor stimulation has altered the expression of these 
proteins but the effect of growth factor stimulation was attenuated when cells were treated 
with SK&F96365. Proteins identified in these clusters are summarised in Table 2.  
Insert Table 2 here 
Fig 4C shows principal component analysis of the data and reveals that the first component 
separates samples based on the treatment of cells with growth factors and component 2 
separated samples according to treatment with SK&F96365. Both principal components 
represent panels of proteins and it was on the expression levels of these proteins that the 
separation between conditions was based. Of interest are the proteins that separate 
samples based on treatment with SK&F96365 and these include; ARHGEF17, ASPSCR1, 
BAK1, BNIP3L, CASP7, CDC26, CDH2, CIT, CRYL1, CTGF, ERC2, EXOSC8, GTF2H4, GTF3C1, 
HIGD1A, HMG20A, MCM3, METTL3, MRPL22, NR4A1, PBRM1, PTAR1, QPCTL, RCL1, 
SLC30A9, TJAP1 and TMOD2 (for more details see Table 3). 
Insert Table 3 here 
In this part of analysis we have identified proteins that appear to be regulated by the 
inhibition of Ca2+ influx. Additionally, hierarchical clustering and principle component 
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analysis allowed to prioritise proteins that are more likely to be involved in Ca2+ dependent 
regulation of the cell cycle. 
Biological interpretation of the data - Biological interpretation of big data sets from 
proteomic screens is a very challenging task. The biggest difficulty is the extraction of 
functional and biological knowledge from the long list of proteins generated during mass 
spectrometry discovery experiments. In recent years pathway analysis has become the first 
choice for understanding and interpretation of the biological significance of the datasets of 
proteins expressed under specific conditions which are generated during proteomic 
discovery experiments [45–48]. Thus, to interpret the biological significance of proteins 
differentially expressed by the inhibition of CCE (panel of 182 proteins), an analysis of 
canonical pathways and biological processes was performed using Ingenuity Pathway 
Analysis (IPA) software.  
An initial pathway analysis was performed to determine canonical pathways that were 
regulated by the inhibition of Ca2+ influx. The top 15 canonical pathways selected by IPA 
were: PI3K/AKT signalling, FAK signalling, mTOR signalling, 14-3-3-mediated signalling, 
insulin receptor signalling, integrin signalling, IGF-1 signalling, regulation of cellular 
mechanics by calpain protease, EGF signalling, protein ubiquitination pathway, ErbB 
signalling, PAK signalling, epithelial adherens junction signalling, actin nucleation by ARP-
WASP complex. Importantly, these pathways can be grouped to the pathways that regulate 
cell proliferation for example PI3K/AKT signalling, insulin receptor signalling, EGF signalling, 
ErbB signalling and pathways that regulate the morphology of the cells for example FAK 
signalling, integrin signalling, PAK signalling, epithelial adherens junction signalling or actin 
nucleation by ARP-WASP complex (data not shown). 
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Subsequently ontology enrichment analysis of the 182 proteins whose expression was 
altered by treatment with SK&F96365 was then performed to determine which of the 
cellular processes were affected by Ca2+ influx inhibition. A total of 182 proteins differently 
expressed in the cells with inhibited Ca2+ influx were grouped into following categories: 
cellular growth and proliferation, cell cycle, cell morphology, cellular assembly and 
organisation, cellular movement, DNA replication, recombination and repair, molecular 
transport, protein degradation, protein synthesis, RNA post-transcriptional modification, cell 
death and survival, and cell to cell signalling and interaction. A summary of the ontology 
enrichment analysis associated with this dataset can be found in Table 4. 
Insert Table 4 here 
It is well established that growth factors acting alone cannot stimulate cell division and cells 
must receive appropriate environmental cues from cell-substrate adhesion [49,50], cell 
shape [51–53] and cell-cell contact [54] to progress through the G1 phase of cell cycle up to 
the R point. Our data suggests that Ca2+ could be a factor that links cell proliferation with 
the environmental cues, cells morphology and cellular assembly and organisation by the 
regulation of the expression of proteins that play a role in all three processes. Subsequently, 
to determine common proteins involved in the regulation of these processes an overlap 
analysis was performed. Forty of the 182 proteins identified as proteins regulated by Ca2+ 
inhibition were found to be associated with cell proliferation, morphology and cellular 
assembly and organisation. Ten proteins have been identified as common proteins involved 
in the regulation of all selected for analysis categories. These proteins included ACP1, 
CDC42, EGFR, F2R, ERBB4, HRAS, IKBKB, PIK3R1, PAX and RHOB. Some proteins such as 
AKT3, EEF1D, EIF3I, EPB41L3, PBXIP1, TSC2, TSG101, TSNAX, TXNIP and UBE2D3 have been 
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exclusively associated with cell proliferation. ABCD1, ARHGEF17, ATG4B, BCS1L, EPB41, 
RHOJ and TBCD were exclusive to the process of cellular assembly and organization and 
RAP2B and TSC2 were found to regulate cell morphology. Ten proteins, VPS4A, CDC42BPA, 
ARFGEF1, CTNNA2, NCKAP1, MAP1B, UCHL1, TBCE, KIF3B and IOP9 were identified as 
proteins involved in the regulation of cell morphology and cellular assembly and 
organization. CDK4 was common in cell proliferation and assembly and organisation. None 
of the proteins were common for cell proliferation and morphology (Fig 5).  
Insert Figure 5 here 
The IPA analysis of biological importance of the data has indicated that Ca2+ signalling may 
regulate cell proliferation via PI3K/AKT signalling and its downstream target mTOR. In 
addition, some other canonical pathways identified such as FAK, integrin, PAK, epithelial 
adherents junction were found to be regulated by Ca2+ influx inhibition and associated with 
the regulation of cell morphology and cellular assembly and organisation.  
Validation of protein expression changes - Proteomic discovery experiments are very 
complex experiments in terms of sample preparation, acquisition and data analysis. Each of 
the steps that are undertaken in proteomic workflow may then account for the variables 
and errors in the estimation of proteins that are differently expressed between investigated 
conditions, termed false discovery rate. Thus, it is important to verify the findings by 
alternative methods applied to investigate protein expression changes for example Western 
blotting [55], Elisa [56] (applied mostly for the secreted proteins), multiple reaction 
monitoring (MRM) [57–59] or imaging followed by staining with specific antibodies [60]. 
Accordingly, to confirm whether the protein expression changes observed in nLC-MS/MS 
analysis are authentic findings, an analysis of protein expression levels of three selected 
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proteins was performed using Western blotting. These proteins, paxillin, HRAS and CDC42 
(proteins marked with asterisks on Fig 5), were selected based on their involvement in 
cellular processes relevant to cell cycle progression and the regulation of cell morphology 
and cellular assembly and organisation. The nLC-MS/MS data obtained for all three proteins 
indicated that they were down-regulated (moderately but with statistical significance) in the 
presence of SK&F96365. Western blot analysis of paxillin (Fig 6A-B), RAS (Fig 6C-D) and 
CDC42 (Fig 6E-F) showed they were all expressed at lower average levels in cells treated 
with SK&F96365. Further density analysis of these proteins bands has shown that the 
relative change of the bands normalised to the density of the internal control GAPDH was 
lower in cells treated with growth factors in the presence of SK&F96365 when compared to 
cells incubated in the presence of growth factors alone. However, only for paxilin this 
change was statistically significant. This data is in close agreement with the nLC-MS/MS 
analysis and provides good evidence to support the authenticity of the nLC-MS/MS dataset 
of Ca2+ influx dependent changes in protein expression (see Supplementary Table 2). To date 
this independent validation of individual protein expression changes has been undertaken 
on 3 proteins. Additional data from Western blot validation are in Supplementary Fig S-8. 
Insert Figure 6 here 
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DISCUSSION 
To our knowledge, this is the first study to report the effect of Ca2+ signalling on growth 
factor induced protein expression in human non-transformed cells on a proteomic scale. 
Ca2+ is universally required for cell cycle progression in non-excitable cells, including 
fibroblasts [6]. Here we show that SK&F96365, an inhibitor of store-operated Ca2+ entry, 
decreases the plateau of serum growth factor induced Ca2+ levels without affecting the 
initial transient increase in Ca2+ in human fibroblasts as previously reported for other cell 
types [9,16,61]. This reduced level of sustained cytoplasmic Ca2+ inhibits cell progression to 
S phase [9,16] an observation shown here for human fibroblasts. Although the role of Ca2+ in 
the cell cycle is well established and, as noted above, several studies have shown that the 
inhibition of Ca2+ influx by pharmacological agents blocks the proliferation of fibroblasts 
[12], epithelial cells [7], brain tumor cells [13] and peripheral blood lymphocytes [14], the 
molecular mechanism(s) by which Ca2+ signalling regulates these events in G1 phase is 
poorly characterised. In particular, the requirement for and impact of Ca2+ influx on growth 
factor induced gene expression during the early stages of G1 has received little attention. To 
address this, we have analysed, on a global proteomic scale, the effect of inhibition of Ca2+ 
influx on growth factor induced protein expression changes early in G1. Using high-
resolution mass spectrometry together with the rigorous sample preparation we have 
routinely identified just over 4,000 proteins in each experimental sample. Whilst the mass 
spectrometry data reported is highly robust and reproducible there are of course significant 
limitations associated with the use of small molecule inhibitors as employed here. 
Inhibitors, such as SK&F96365, may be expected to exhibit low specificity and off-target 
effects. To partially address this issue and to evalaute the effectiveness of an inhibitor it is 
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common to investigate and report the concentration of the molecule which is required to 
induce a half-maximal inhibitory effect (IC50). In many of the experiments described here the 
optimal inhibitory concentration of SK&F96356 was 60 µM and an IC50 of ~30 µM was 
observed. Both are close to the upper limits reported by others [14,15] and suggest that, in 
the experiments reported here SK&F96365 may have off target (non-specific) effects. 
Notably, in addition to its effect on various Ca2+ channels at high concentrations SK&F96365 
may also inhibit K+ currenst [62]. Notably, Labelle et al. [63] have shown that SK&F96365 
may inhibit cytochrome P450  and prostaglandin E2 pathways but that this does not account 
for the ability of the drug to inhibit cell proliferation. It is evident therefore that the 
potential direct association  of Ca2+ influx  and the protein changes reported here will 
require further investigation. 
The global analysis presented in this manuscript represents the data of single time point 
analysis of two highly dynamic and time dependent processes of cell division and Ca2+ influx. 
Indeed, addition of another time point or using different cell treatment pattern (for example 
treatment of cells with SK&F96365 30 minutes after addition of growth factors) would 
improve confidence of current findings. Nevertheless, even in light of these limitations, the 
data presented here provide a valid source of information of complete set of protein 
expression changes regulated by Ca2+, their rates of change and involvement in the 
regulation of biological processes. Furthermore, identified proteins provide numerous 
opportunities for more detailed investigations of the mechanism of Ca2+ dependent 
regulation of cell cycle at the molecular and systemic level. 
Evaluation of data quality by analysis of features such as; distribution of total ion current 
chromatograph (TIC) traces, proteome coverage and protein LFQ intensities between 
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technical and biological replicates has shown that applied in this project nLC-MS/MS 
strategy is robust and reproducible. Normal distribution of TIC’s traces and highly consistent 
total ion current chromatograms between technical and biological replicates (Fig 3A-B) has 
confirmed that unlikely any variances have been introduced at the level of sample 
preparation or sample acquisition. High similarity in LFQ intensities of measured proteins 
between technical and biological replicates with Pearson correlation 0.99 assured good 
reproducibility in measured proteins intensities. In addition, most of the proteins have been 
identified in each technical and biological replicates and only 5 % of the total number of 
proteins identified was represented by missing values. Notably, good correlation has been 
found across the output data from different analysis steps. For example, hierarchical 
clustering and PCA analysis grouped the samples according to the replicates and each 
treatment condition was clearly separated. In addition, IPA analysis indicated that processes 
of fibroblast proliferation, cell shape changes and cell migration may be negatively regulated 
in cells treated with SK&F96365. Subsequent functional analysis of these biological 
processes have confirmed that cells treated with SK&F96365 (i) do not proliferate and are 
arrested in G0/G1 (Fig 1B-D), (ii) have altered morphology (Supplementary Fig S-2) and (iii) 
do not migrate (Supplementary Fig S-3). Altogether, this data demonstrates that highly 
reproducible and comprehensive analysis of protein expression was obtained using total cell 
lysates of non-transformed primary human lung fibroblasts (MRC-5 cells). 
Statistical analysis of 4411 common proteins identified between all experimental conditions 
has shown that incubation of cells with growth factors in the presence of SK&F96365 (60 
µM) significantly changed the expression of 182 proteins (Fig 4A). To the protein expression 
changes observed in this study several mechanisms can contribute for example activation of 
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immediate early genes [64] and further transcription and translation of the protein [65]. 
Some other processes such as protein stabilisation (associated with increased protein 
abundance) or protein degradation (accompanied by the decrease in protein abundance) 
[66] also contribute to these protein expression changes. Data presented in here has shown 
that majority of the proteins (111 proteins) were found to be down-regulated in presence of 
SK&F96365 and this in turn may suggest that Ca2+ at selected time point more likely 
regulates the mechanism(s) associated with stabilisation, transcription and translation of 
the protein. Further application of hierarchical clustering and PCA analysis has shortlisted a 
number of proteins regulated significantly by Ca2+ influx. Selected by this analysis proteins 
may provide possible insights into Ca2+ dependent regulation of G1. For example, one 
possibility is that Ca2+, by affecting protein expression, may disrupt the interaction between 
the RHOA protein [67] and its activator Rho guanine nucleotide exchange factor 17 
(ARHGEF17). Importantly, GSN, TUBB and CTNNA2 proteins, which were also found to 
change here, have previously been shown to interact with ARHGEF17 [68] (for details see 
Supplementary Table 2). In contrast to ARHGEF17, which was upregulated, the interacting 
proteins were down regulated. Some other proteins identified here including TMOD2 (or 
CIT) have also been shown to be connected with ARHGEF17 and RHOA [69,70]. Importantly, 
it appears that all these proteins create a network associated with the regulation of the 
cytoskeleton and cell proliferation with RHOA being the central node. Elegant studies 
conducted by Huang et al. [71] have demonstrated a possible link between proteins that are 
involved in the regulation of cell shape and cell cycle progression. Changes in cell 
morphology, such as cell rounding (a process that was also observed in this study; 
Supplementary Fig S-2) and cytoskeletal reorganisation are associated with decreased levels 
of cyclin D and an increased level of CKI, the p27Kip1. These two key proteins are involved in 
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the transition of cells through the R point, late in G1 phase. Interestingly, Hu et al. have 
shown that the degradation of p27Kip1 depends on RHOA [72] and it is possible that Ca2+ 
signalling may be necessary for the RHOA dependent degradation of p27Kip1. The above 
evidence supports a possible mechanism in which the altered expression of ARHGEF17 and 
its interacting partners limit the activation of RHOA and subsequent degradation of p27Kip. 
Under these conditions the cyclin E/CDK2 complex would remain inactive so arresting cells 
in G1 at the R point (for details see Fig 7). The observation that Ca
2+ plays a role at the R 
point transition has been reported before [15,73]. Notably, it has been shown that Ca2+ 
regulates the expression of two key G1 phase regulatory proteins, cyclin D [74] and cyclin E 
[15] at the restriction point. In addition, it has been shown that Ca2+ is involved in the 
regulation of expression of p21Cip1/Waf1/Sdi1 and p27Kip1 with inhibition of Ca2+ influx resulting 
in up-regulation of both p21Cip1/Waf1/Sdi1 [19,75] and p27Kip1 [15] and cell cycle arrest at R [30]. 
Insert Figure 7 here 
Some interesting observations and conclusions came also from the IPA analysis of 182 
proteins which expression was found to be regulated by Ca2+ influx inhibition. Interestingly, 
this analysis has indicated that the inhibition of Ca2+ influx in MRC-5 cells likely affects the 
proliferation of the cells via the regulation of canonical PI3K/AKT signalling and its 
downstream target mTOR. A study by Gao et al. has shown that the inhibition of PI3K/AKT 
by LY294002 inhibitor in prostate cancer cell lines DU145 and PC-3 decreases the 
phosphorylation of AKT and the expression of the key cell cycle molecules such as cyclin D1, 
CDK4 [76]. In addition, treatment of cells with LY294002 upregulates the expression of cyclin 
kinase inhibitor p21CIP1/WAF1 and prevents the phosphorylation of Rb protein at Ser780, 
Ser795 and Ser807/811 [76]. Casagrande et al. have reported similar observation in the 
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choroidal melanoma cell, demonstrating that the treatment of cells with the LY294002 
inhibitor upregulates the expression of cyclin kinase inhibitor p27Kip1 and prevents 
functional activity of CDK4 and CDK2[77]. Furthermore, Gao et al. have shown that 
inhibition of PI3K/AKT by LY294002 affects the function of AKT downstream target, the 
mammalian target of rapamycin (mTOR) and prevents the phosphorylation of mTOR 
substrate the p70S6K protein involved in the regulation of the expression of p21CIP1/WAF1 and 
G1/S transition[76]. Blocking the mTOR pathway with inhibitors such as rapamycin or PI-103 
prevents cell proliferation by cell cycle arrest in G0/G1 phase. The subsequent molecular 
mechanism involves downregulation of cyclin D1 and E1 and upregulation of p21CIP1/WAF1, 
p27Kip1 and p53 [78,79]. Thus, it is possible that proteins selected by IPA analysis such as 
MAPKAP1, RHOB, PIK3R1, TSC2, EIF3I, AKT3, HRAS, RHOJ or IKBKB contribute to the 
described Ca2+ dependent mechanisms of PI3K/AKT and mTOR regulation of cell cycle.   
When quiescent cells (in G0) are exposed to growth factors and mitogens a series of 
intracellular signalling events are initiated that control entry into and progression through 
G1. However, growth factors acting alone cannot stimulate cell division and the presence of 
appropriate environmental stimuli from cell-substrate adhesion [49,50], cell shape [51–53] 
and cell-cell contact [54] cells must be provided for successful progression through the G1 
phase of cell cycle up to the R point. Notably, in addition to cell proliferation some pathways 
identified by IPA such as FAK, integrin, PAK, epithelial adherents junction signalling and actin 
nucleation by ARP-WASP complex are associated with the regulation of the cell-substrate 
adhesion, cell shape and cell-cell contact. Accordingly, the analysis of biological processes 
has indicated that indeed cellular assembly and organisation and cell morphology are the 
processes regulated by the inhibition of Ca2+ influx. In addition, IPA analysis predicted that 
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processes such as cell shape, cell spreading and most of the processes associated with the 
cellular assembly and organisation (Table 4) may be negatively regulated in cells treated 
with SK&F96365. Interestingly, comparative analysis of cell proliferation, cell morphology 
and cellular assembly and organisation has indicated proteins that are involved in all three 
processes. The common proteins identified ACP1, CDC42, EGFR, IKBKB, ERBB4, F2R, RHOB, 
HRAS, PIK3R1 and PAX may be potential candidates that could link Ca2+ signalling with the 
cell shape and/or cell substrate adhesion dependent regulation of G1 phase. One attractive 
scenario could be that Ca2+ signalling regulates the expression or activity of proteins that 
belong to the family of small GTPases that are known to regulate cell shape, cellular 
assembly and organisation and proliferation. Indeed three proteins HRAS, CDC42 and RHOB 
that belong to the family of small GTPases have been identified in the panel of common 
proteins. Expression of all of these proteins was found to be down-regulated in the presence 
of SK&F96365. Subsequent analysis of the importance of these proteins by scientific groups 
has established their role in cell cycle progression. Unquestionably, RAS, RHO and CDC42 
proteins are necessary for cell cycle progression, most importantly progression through the 
G1 phase of cell cycle [80]. It is also evident that all of these proteins play a role in cell 
adhesion and morphology. For example, it has been reported that overexpression of a 
dominant negative mutant of CDC42 inhibits integrin-dependent cell spreading [81]. At the 
same time microinjection of constitutively activated CDC42 to quiescent Swiss 3T3 
fibroblasts induces G1 progression and DNA synthesis [82]. The importance of H-RAS has 
been demonstrated by the observation that the downregulation of its expression by siRNA 
reduces proliferation of T80H cells (by cell cycle arrest in G0/G1 phase) [83] and the 
overexpression of H-RAS in normal human fibroblasts alters cell shape causing rounding up 
of the cells [84]. Notably, the activation of RAS occurs immediately and transiently following 
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addition of growth factors to quiescent cells and then again in mid G1 [85] and both the RAS-
Raf-Mek-Erk and RAS-PI3K-PDK1-AKT/PBK signalling pathways are required for cell cycle 
entry and progression through G1 [86–88]. As shown by multiple studies, the main function 
of RAS protein in G1 phase progression is to inactivate Rb protein, the key molecular 
mechanism that drives the transition of the cells from G1 to S phase [89,90]. RHOB seems to 
have a negative effect on cell proliferation through its ability to supress the K-RAS, N-RAS or 
H-RAS oncogenes [91]. However, in prostate cancer cell lines down-regulation of RHOB 
reduces cell spreading, alters cell morphology [92] but has no effect on cell proliferation 
[93]. Ca2+ influx dependent changes were also observed in the expression of paxillin. The 
important role of this protein in cell cycle progression has been well documented and 
numerous studies have shown that overexpression of paxillin mRNA and stabilisation of 
protein by phosphorylation increase the rate of cell proliferation [94,95]. As might be 
expected, siRNA mediated down-regulation of paxillin expression significantly inhibits cell 
cycle progression [95].  
Conclusions: In summary, the results presented here demonstrate the application of mass 
spectrometry based proteomics in the analysis of Ca2+ dependent regulation of cell cycle. 
Careful experimental design, the application of robust sample preparation methods, and the 
use of sensitive mass spectrometry resulted in highly reproducible and comprehensive 
analysis of protein expression changes in non-transformed primary human lung fibroblasts 
(MRC-5 cells). Application of this highly robust and accurate proteomic workflow allowed 
the identification of 182 novel proteins regulated by Ca2+ signalling. The data presented in 
here represents the biggest to date dataset of proteins regulated by Ca2+ signalling and 
provides numerous opportunities for more detailed investigations of the mechanism of Ca2+ 
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dependent regulation of cell cycle at the molecular and system level. Proposed in here 
possible mechanism is one attractive scenario, which can be used as a starting point to 
begin this type of the research. Moreover, the data highlights that identified proteins in 
addition to the regulation of cell division are also involved in the regulation cell morphology 
and cellular assembly and organization, the environmental clues, which are known to 
regulate cell proliferation. Common proteins involved in the regulation of these processes 
may provide the link between Ca2+, cell morphology and cell proliferation an environmental 
cues on which division depends.  
The comprehensive proteomic dataset reported here has been made publically available 
(http://proteomecentral.proteomexchange.org) and provides a rich source of information 
that will underpin further investigation of the molecular mechanism(s) of Ca2+ influx 
dependent regulation of mammalian cell cycle entry and cell cycle progression to G1 and 
beyond. We suggest that this may pave the way for a more detailed and comprehensive 
temporal survey of Ca2+ dependent regulation of growth factor induced protein expression 
changes as cells progress through the cell cycle.  
All mass spectrometry proteomics data have been uploaded to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE. Dataset can be 
accessed using identifier PXD002303. 
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false discovery rate; IPA, Ingenuity Pathway Analysis; MS/MS, tandem mass spectrometry; 
nLC, nano Liquid Chromatography; R point, restriction point late in G1 phase; Rb, 
Retinoblastoma protein; SK&F96365, selective inhibitor of CCE (1-[2-(4-Methoxyphenyl)-2-
[3-(4-methoxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride). 
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Table 1. List of 10 most down-regulated and up-regulated proteins identified in cells with 
inhibited Ca2+ influx. Protein ID, protein name, gene name, log2 fold change, and p-value is 
listed for each protein. 
Protein IDs Protein names Gene names Log2 fold change 
G+/G 
t-test p-value 
G+/G 
Top ten down-regulated proteins 
P26232 Catenin alpha-2 CTNNA2 -26.40 8.85E-06 
Q5VST9 Obscurin OBSCN -25.01 2.56E-08 
P36021 Monocarboxylate 
transporter 8 
SLC16A2 -23.92 1.81E-06 
Q58DX5 Inactive N-acetylated-
alpha-linked acidic 
dipeptidase-like protein 2 
NAALADL2 -23.87 3.94E-06 
Q96EY5 Multivesicular body 
subunit 12A 
MVB12A -23.67 1.05E-06 
Q9H3M7 Thioredoxin-interacting 
protein 
TXNIP -2.20 6.74E-03 
Q96A35 39S ribosomal protein L24, 
mitochondrial 
MRPL24 -1.89 2.41E-02 
Q5J8M3 ER membrane protein 
complex subunit 4 
EMC4 -1.77 3.96E-02 
Q9NSK7 Protein C19orf12 C19orf12 -1.52 1.78E-02 
Q9BVL4 Selenoprotein O SELO -1.44 3.63E-02 
Top ten up-regulated proteins 
Q9NXS2 Glutaminyl-peptide 
cyclotransferase-like 
protein 
QPCTL 25.28 3.77E-09 
Q8WU79 Stromal membrane-
associated protein 2 
SMAP2 24.67 1.01E-07 
Q96PE2 Rho guanine nucleotide 
exchange factor 17 
ARHGEF17 23.95 2.72E-07 
Q7Z6K3 Protein prenyltransferase 
alpha subunit repeat-
containing protein 1 
PTAR1 21.87 2.12E-07 
Q12789 General transcription 
factor 3C polypeptide 1 
GTF3C1 4.03 3.91E-02 
P53539 Protein fosB FOSB 3.54 2.62E-04 
Q9UHA3 Probable ribosome 
biogenesis protein RLP24 
RSL24D1 2.29 1.81E-02 
Q96EC8 Protein YIPF6 YIPF6 2.00 3.67E-03 
Q5MNZ9 WD repeat domain 
phosphoinositide-
interacting protein 1 
WIPI1 1.72 1.99E-02 
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O60238 BCL2/adenovirus E1B 19 
kDa protein-interacting 
protein 3-like 
BNIP3L 1.56 3.19E-02 
 
Table 2. List of proteins selected by heat map analysis. Protein ID, protein name, gene 
name and p-value is listed for each protein. 
Protein ID Protein name Gene name ANOVA p-value 
Q96PE2 
Rho guanine nucleotide exchange factor 
17 ARHGEF17 2.89E-12 
Q7Z6K3 
Protein prenyltransferase alpha subunit 
repeat-containing protein 1 PTAR1 5.22E-12 
O95163 Elongator complex protein 1 IKBKAP 1.80E-03 
Q5T1M5 FK506-binding protein 15 FKBP15 3.54E-02 
Q9Y2S2 Lambda-crystallin homolog CRYL1 3.46E-02 
Q9NZR1 Tropomodulin-2 TMOD2 4.45E-02 
Q8NHZ8 
Anaphase-promoting complex subunit 
CDC26 CDC26 4.47E-02 
O60238 
BCL2/adenovirus E1B 19 kDa protein-
interacting protein 3-like BNIP3L 4.05E-02 
Q96GK7 
Fumarylacetoacetate hydrolase domain-
containing protein 
2A;Fumarylacetoacetate hydrolase 
domain-containing protein 2B FAHD2A;FAHD2B 4.64E-02 
Q9NS86 LanC-like protein 2 LANCL2 2.93E-02 
P98194 
Calcium-transporting ATPase type 2C 
member 1 ATP2C1 3.98E-02 
Q92759 General transcription factor IIH subunit 4 GTF2H4 4.59E-02 
Q12789 
General transcription factor 3C 
polypeptide 1 GTF3C1 3.67E-02 
Q16611 Bcl-2 homologous antagonist/killer BAK1 4.35E-02 
Q9NP66 High mobility group protein 20A HMG20A 4.52E-02 
O14578 Citron Rho-interacting kinase CIT 4.82E-02 
Q9UQ13 Leucine-rich repeat protein SHOC-2 SHOC2 5.55E-03 
Q96B26 Exosome complex component RRP43 EXOSC8 4.24E-02 
P49815 Tuberin TSC2 8.49E-03 
Q96J02 E3 ubiquitin-protein ligase Itchy homolog ITCH 4.93E-02 
O95989 
Diphosphoinositol polyphosphate 
phosphohydrolase 1 NUDT3 4.14E-02 
Q99622 Protein C10 C12orf57 1.44E-02 
 
Table 3. List of proteins selected by PCA. Protein ID, protein name, gene name, rank order 
and p-value is listed for each protein. 
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Protein IDs Protein names Gene names Rank order ANOVA p-value 
Q9NXS2 
Glutaminyl-peptide 
cyclotransferase-like protein QPCTL 1 4.31E-03 
P22736 
Nuclear receptor subfamily 4 
group A member 1 NR4A1 2 6.32E-03 
Q9Y241 
HIG1 domain family member 1A, 
mitochondrial HIGD1A 3 8.20E-03 
Q86U86 Protein polybromo-1 PBRM1 4 3.13E-12 
Q96PE2 
Rho guanine nucleotide exchange 
factor 17 ARHGEF17 5 2.89E-12 
Q12789 
General transcription factor 3C 
polypeptide 1 GTF3C1 6 3.67E-02 
Q7Z6K3 
Protein prenyltransferase alpha 
subunit repeat-containing 
protein 1 PTAR1 7 5.22E-12 
O14578 Citron Rho-interacting kinase CIT 8 4.82E-02 
Q9NP66 High mobility group protein 20A HMG20A 9 4.52E-02 
Q16611 
Bcl-2 homologous 
antagonist/killer BAK1 10 4.35E-02 
Q92759 
General transcription factor IIH 
subunit 4 GTF2H4 11 4.59E-02 
Q6PML9 Zinc transporter 9 SLC30A9 12 3.05E-12 
Q5JTD0 
Tight junction-associated protein 
1 TJAP1 13 1.60E-11 
Q9NZR1 Tropomodulin-2 TMOD2 14 4.45E-02 
Q9Y2S2 Lambda-crystallin homolog CRYL1 15 3.46E-02 
P55210 
Caspase-7;Caspase-7 subunit 
p20;Caspase-7 subunit p11 CASP7 16 1.73E-12 
O60238 
BCL2/adenovirus E1B 19 kDa 
protein-interacting protein 3-like BNIP3L 17 4.05E-02 
Q8NHZ8 
Anaphase-promoting complex 
subunit CDC26 CDC26 18 4.47E-02 
P25205 
DNA replication licensing factor 
MCM3 MCM3 19 6.17E-03 
Q96B26 
Exosome complex component 
RRP43 EXOSC8 20 4.24E-02 
Q9BZE9 
Tether containing UBX domain 
for GLUT4 ASPSCR1 21 3.56E-02 
Q86U44 
N6-adenosine-methyltransferase 
70 kDa subunit METTL3 22 4.65E-03 
Q9NWU5 
39S ribosomal protein L22, 
mitochondrial MRPL22 23 1.00E-02 
P19022 Cadherin-2 CDH2 24 8.13E-03 
Q9Y2P8 
RNA 3-terminal phosphate 
cyclase-like protein RCL1 25 8.59E-03 
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O15083 ERC protein 2 ERC2 26 7.05E-03 
P29279 Connective tissue growth factor CTGF 27 2.80E-03 
O00622 Protein CYR61 CYR61 28 1.64E-03 
O95870 
Abhydrolase domain-containing 
protein 16A ABHD16A 29 9.63E-03 
 
Table 4. List of biological processes associated with 182 proteins that were found to be 
differentially expressed in cells with inhibited Ca2+ influx. Categories, functional 
annotation, p-value, activation z-score, molecules and number of molecules is listed for 
each biological process. 
Categories 
 Functions 
Annotation p-value 
Activation 
z-score Molecules 
# 
Molecules 
Protein 
Degradation, 
Protein 
Synthesis 
catabolism of 
protein 1.51E-06  0 
ATG4B,EGFR,NEDD8,PSMB3, 
PSMD14,PSMF1,UBE2D2,UBE2D3, 
UBE2K,UCHL1 10 
RNA Post-
Transcriptional 
Modification 
splicing of 
RNA 2.15E-06 -1.34 
CDC42,EPB41,HNRNPH3,LUC7L3, 
PPIH,SAP18,SNRPD1,SNRPF,SRSF9 9 
Cellular 
Assembly and 
Organization 
development 
of cytoplasm 3.07E-06 -1.93 
ABCD1,ARHGEF17,ATG4B,CDC42, 
CDK4,EGFR,F2R,HRAS,IKBKB,IPO9, 
MAP1B,PXN,RHOB,TBCD,TBCE,VPS4A 16 
Protein 
Degradation, 
Protein 
Synthesis 
degradation 
of protein 4.09E-06 0 
ATG4B,EGFR,IKBKB,IPO9,NCKAP1, 
NEDD8,PIK3R1,PSMB3,PSMD14, 
PSMD2,PSMF1,TSG101,UBE2D2, 
UBE2D3,UBE2K,UCHL1,UFSP2,VPS4A 18 
Protein 
Synthesis 
metabolism of 
protein 9.12E-06 -0.66 
ATG4B,CDK4,EGFR,EIF3I,GPC1,IKBKB, 
IPO9,NCKAP1,NEDD8,PIK3R1,PSMB3, 
PSMD14,PSMD2,PSMF1,RPL19,TSC2, 
TSG101,UBE2D2,UBE2D3,UBE2K, 
UCHL1,UFSP2,UPF1,VPS4A 24 
Cellular 
Movement 
cell 
movement of 
fibroblast cell 
lines 1.05E-05 -0.34 
ACP1,ADI1,CDC42,EGFR,ERBB4, 
GPC1,HRAS,PIK3R1,PXN 9 
Cellular Growth 
and 
Proliferation 
proliferation 
of fibroblast 
cell lines 1.24E-05 -0.21 
ACP1,CDC42,CDK4,EEF1D,EGFR, 
EIF3I,ERBB4,F2R,HRAS,IKBKB, 
PIK3R1,RHOB,TSC2,TSNAX,TXNIP 15 
Cell 
Morphology 
shape change 
of fibroblasts 2.09E-05 -0.42 CDC42,HRAS,PXN,RHOB,TSC2 5 
RNA Post-
Transcriptional 
Modification 
processing of 
RNA 3.41E-05 -1.342 
CDC42,EPB41,HNRNPH3,LUC7L3, 
PPIH,SAP18,SNRPD1,SNRPF,SRSF9, 
UPF1,WDR43 11 
Cellular Growth 
and 
Proliferation 
colony 
formation of 
fibroblast cell 
lines 1.02E-04 0.26 
CDC42,EGFR,ERBB4,HRAS,RHOB, 
TSC2 6 
Cellular 
Assembly and 
Organization 
formation of 
cytoskeleton 1.13E-04 -2.11 
ARHGEF17,CDC42,CDK4,EGFR,F2R, 
HRAS,IKBKB,MAP1B,PXN,RHOB, 
TBCD,TBCE 12 
Cellular 
Assembly and 
Organization 
quantity of 
filaments 1.19E-04 -0.34 
CDC42,EPB41,HRAS,MAP1B,RHOB, 
RHOJ,TBCE 7 
Cell 
Morphology 
cell spreading 
of tumor cell 
lines 1.36E-04 -1.34 
CDC42,EGFR,HRAS,PXN,RAP2B, 
UCHL1 6 
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Cellular 
Assembly and 
Organization 
formation of 
actin stress 
fibers 1.81E-04 -2.41 
ARHGEF17,CDC42,CDK4,EGFR,F2R, 
HRAS,IKBKB,PXN,RHOB 9 
Cell Death and 
Survival 
apoptosis of 
fibroblast cell 
lines 2.22E-04 -0.34 
CDK4,EGFR,EIF3I,ERBB4,HRAS,IKBKB, 
MAPKAP1,PIK3R1,RHOB,TSC2,TXNIP 11 
Cellular 
Assembly and 
Organization 
formation of 
filaments 3.19E-04 -2.11 
ARHGEF17,CDC42,CDK4,EGFR,F2R, 
HRAS,IKBKB,MAP1B,PXN,RHOB,TBCD, 
TBCE 12 
Cellular 
Assembly and 
Organization 
retraction of 
cellular 
protrusions 4.38E-04 -0.28 CDC42,CDC42BPA,F2R,HRAS,MAP1B 5 
Cellular Growth 
and 
Proliferation 
arrest in 
proliferation 
of cells 5.86E-04  0 
AKT3,CDC42,CDK4,EGFR,HRAS,IKBKB, 
TSG101,UBE2D3 8 
Molecular 
Transport 
transport of 
molecule 5.96E-04 -1.36 
ABCD1,AGK,AKT3,ARFIP1,CDC42,CDK4, 
CHMP3,ENSA,ERBB4,F2R,GAR1,HRAS, 
IKBKB,IPO9,MAP1B,MAPKAP1,PHAX, 
PIK3R1,PKN1,RHOB,SLC16A2,SLC25A20, 
SLC33A1,TSC2,TSG101,TSNAX,TXNIP, 
UPF1,VPS4A 29 
RNA Post-
Transcriptional 
Modification 
splicing of 
mRNA 7.10E-04   HNRNPH3,PPIH,SAP18,SNRPD1,SRSF9 5 
Molecular 
Transport 
transport of 
protein 8.06E-04  0 
ARFIP1,CHMP3,IPO9,MAP1B,RHOB, 
TSC2,TSG101,TSNAX,TXNIP 9 
Cell 
Morphology cell spreading 9.01E-04 -0.56 
ACP1,CDC42,EGFR,HRAS,IPO9,PXN, 
RAP2B,RHOB,UCHL1 9 
Cell 
Morphology 
reorganization 
of 
cytoskeleton 1.05E-03 -1.18 
CDC42,CDC42BPA,EGFR,F2R,HRAS, 
PXN,RHOB 7 
Cell Death and 
Survival 
apoptosis of 
ovarian cancer 
cell lines 1.09E-03 -1.98 EGFR,ERBB4,HRAS,IKBKB,TSG101 5 
Cell Death and 
Survival 
cell death of 
fibroblasts 1.74E-03 -0.94 
CDC42,EGFR,HRAS,IKBKB,RHOB, 
TSC2,TSG101,UBE2K 8 
Cell 
Morphology 
formation of 
lamellipodia 1.93E-03 -0.60 
CDC42,EGFR,HRAS,NCKAP1, 
PXN,RHOB 6 
DNA 
Replication, 
Recombination, 
and Repair 
synthesis of 
DNA 2.04E-03 -1.36 
CDC42,CDK4,EGFR,ERBB4,F2R,HRAS, 
IKBKAP,PIK3R1,PXN,TSC2,WDR11 11 
Cellular 
Assembly and 
Organization 
organization 
of actin 
cytoskeleton 2.83E-03  0 
ARHGEF17,CDC42,CDC42BPA,EGFR, 
EPB41,HRAS,RHOB,RHOJ 8 
Cell Death and 
Survival cell death 3.88E-03 -0.80 
ABCD1,ACP1,ADI1,AKT3,BRCC3,CBR1, 
CDC42,CDK4,CHMP3,CTNNA2,DDX19A, 
EEF1D,EGFR,EIF3I,EPB41,ERBB4,F2R, 
FAHD2A,GPC1,HRAS,IKBKAP,IKBKB, 
MAP1B,MAPKAP1,MCM2,MSI1,MSI2, 
NCKAP1,NEDD8,NLE1,OBSCN,PIGT, 
PIK3R1,PKN1,PSMD14,PSMD2,PUM1, 
PXN,RGS10,RHOB,RHOJ,SAP18, 
ST3GAL1,TBCE,TSC2,TSG101,TXNIP, 
UBE2K,UCHL1,UPF1 50 
Cellular 
Movement 
cell 
movement of 
fibroblasts 4.40E-03 -2.40 CDC42,F2R,HRAS,IKBKB,PXN,RHOB 6 
Cellular 
Assembly and 
Organization 
organization 
of cytoplasm 4.69E-03 -0.24 
ABCD1,ACP1,ARFGEF1,ARHGEF17, 
BCS1L,CDC42,CDC42BPA,CTNNA2, 
EGFR,EPB41,ERBB4,F2R,HRAS,IKBKB, 
KIF3B,MAP1B,NCKAP1,PIK3R1,PXN, 
RHOB,RHOJ,TBCD,TBCE,UCHL1 24 
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Cell-To-Cell 
Signaling and 
Interaction 
attachment of 
cells 5.39E-03 0.11 ACP1,EGFR,HRAS,IPO9,RHOB 5 
Cellular 
Assembly and 
Organization 
formation of 
focal 
adhesions 5.71E-03   CDC42,CDC42BPA,HRAS,PXN,RHOB 5 
Cell Death and 
Survival 
apoptosis of 
fibroblasts 7.98E-03 -0.22 CDC42,EGFR,HRAS,IKBKB,RHOB,TSC2 6 
Cell 
Morphology neuritogenesis 7.99E-03 1.57 
CDC42,CTNNA2,EGFR,ERBB4,HRAS, 
KIF3B,MAP1B,PXN,RHOB,TBCE,UCHL1 11 
Cell 
Morphology 
branching of 
neurites 9.50E-03 1.67 
CDC42,CTNNA2,ERBB4,HRAS, 
KIF3B,MAP1B,RHOB 7 
Cellular 
Assembly and 
Organization 
microtubule 
dynamics 1.12E-02 0.08 
ACP1,CDC42,CDC42BPA,CTNNA2, 
EGFR,EPB41,ERBB4,F2R,HRAS,IKBKB, 
KIF3B,MAP1B,NCKAP1,PIK3R1, 
PXN,RHOB,TBCD,TBCE,UCHL1 19 
Molecular 
Transport 
localization of 
protein 1.20E-02   CDC42,NCKAP1,NEDD8,PIK3R1,TSC2 5 
Cellular Growth 
and 
Proliferation 
colony 
formation 1.21E-02 -0.52 
CDC42,EGFR,EPB41L3,ERBB4,HRAS, 
IKBKB,PBXIP1,PIK3R1,PXN,RHOB,TSC2 11 
Cell 
Morphology 
formation of 
cellular 
protrusions 1.25E-02 1.03 
ACP1,CDC42,CDC42BPA,CTNNA2, 
EGFR,ERBB4,HRAS,IKBKB,KIF3B, 
MAP1B,NCKAP1,PXN,RHOB,TBCE, 
UCHL1 15 
Cellular Growth 
and 
Proliferation 
proliferation 
of fibroblasts 1.42E-02 -0.50 
ACP1,CDK4,EGFR,HRAS,IKBKB, 
TSC2,TSG101,TXNIP 8 
Cellular 
Assembly and 
Organization 
organization 
of 
cytoskeleton 1.43E-02 -0.24 
ACP1,ARHGEF17,CDC42,CDC42BPA, 
CTNNA2,EGFR,EPB41,ERBB4,F2R, 
HRAS,IKBKB,KIF3B,MAP1B,NCKAP1, 
PIK3R1,PXN,RHOB,RHOJ,TBCD,TBCE, 
UCHL1 21 
Cell Cycle mitogenesis 1.47E-02 0.85 EGFR,ERBB4,HRAS,IKBKB,PIK3R1 5 
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FIGURE CAPTIONS 
Figure 1. An effect of SK&F96365 on Ca2+ influx and cell cycle progression. [A] Typical 
cytoplasmic Ca2+ traces of quiescent MRC-5 cells stimulated with serum growth factors in 
the presence and absence of Ca2+ influx inhibitor, SK&F96365. Ca2+ traces represent an 
average 340/380 ratio of Fura-2 acquired from single cells in a single experiment 
(approximately n = 10 cells). Figure is a representative figure of five independent 
experiments. [B] Effect of SK&F96365 on the distribution of cells at distinct phases of cell 
cycle upon stimulation of quiescent cells with serum growth factors. MRC-5 cells stimulated 
with serum growth factors in the absence and presence of SK&F96365 were stopped 20 h 
after stimulation, fixed and stained with PI. An intensity of PI was acquired by flow 
cytometry. Data are an average ± SD of three independent experiments. [C] Dose response 
effect of SK&F96365 on entry of MRC-5 cell to S phase. Quiescent MRC-5 cells stimulated 
with serum growth factors in the presence of increasing amounts of SK&F96365. Cells were 
stopped 20 h after treatment and % of the cells in S phase was evaluated by flow cytometry 
analysis of PI staining of fixed cells. Data are an average ± SD of three independent 
experiments. [D] Effect of SK&F96365 on cell cycle progression upon stimulation of 
quiescent cells with serum growth factors. Quiescent cells were loaded with CFSE and then 
stimulated with serum growth factors in the absence and presence of SK&F96365 to 
monitor an effect of inhibition of Ca2+ influx on cell proliferation. CFSE intensity was 
analysed 48 h after stimulation by flow cytometry. Data are an average ± SEM of three 
independent experiments. 
Figure 2. Schematic illustration of sample preparation and analysis of label-free discovery 
experiment. Three biological replicates of MRC-5 cells of four treatment conditions C, C+, G 
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and G+ were lysed in SDS based lysis buffer and protein concentration was determined with 
BCA assay. The lysates were digested according to FASP procedure. Peptides were 
quantified with NanoDrop and then desalted on StageTips prior to analysis on Q-Exactive. 
Each biological replicate was analysed in two technical replicates on the Q-Exactive. Quality 
of data from nLC-MS/MS analysis was visually inspected with XcaliburTM. Proteins were 
identified and quantified in MaxQuant and the selection of statistically important proteins 
was performed in Perseus. Biological importance of the data was analysed with IPA. 
Selected findings were validated by functional assays and Western blot analysis.  
Figure 3. Representative illustration of the quality of nLC-MS/MS data. Representative 
total ion current (TIC) chromatograms of summed intensities detected from nLC-MS/MS 
analysis of control samples at each time point. TICs show an analysis of MRC-5 whole cell 
digest of [A] technical and [B] biological replicates. The x-axis represents the time of 
acquisition and the y-axis relative abundance of the ions. Dot plots show the correlation 
between LFQ intensities of [C] technical and [D] biological replicates of control samples and 
the numbers represent the Pearson’s correlation values for each dot plot. Venn diagrams of 
proteins identified in MRC-5 cell lysates are shown. [E] Comparison of the total number of 
proteins identified in two technical replicates of control cells and [F] the overlap of number 
of proteins identified in three biological replicates of control cells indicates excellent 
experimental reproducibility. 
Figure 4. Effect of Ca2+ influx on protein expression during cell cycle initiation and 
progression. [A] Volcano plot showing protein expression changes in MRC-5 cells stimulated 
with growth factors in the presence of SK&F96365.  indicates proteins that significantly 
change at p < 0.05 [B] Unsupervised hierarchical clustering was performed on protein 
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expression profiles of three biological replicates of control cells (C), control cells treated 
with SK&F96365 (C+), cells stimulated with mixture of growth factors (G) and cells 
stimulated with mixture of growth factors in the presence of SK&F96365 (G+) differentially 
expressed between investigated conditions. The heat map of 291 proteins differentially 
expressed proteins based on clustering are shown in this figure. Each column represents a 
different treatment condition plotted as a three biological replicates and each row 
represents a proteins. Blue indicates proteins that were up-regulated and yellow indicates 
proteins that were down-regulated. Black shows proteins whose expression is unchanged 
between investigated conditions. [C] Principal Component Analysis (PCA) of control (C), 
control cell in the presence of SK&F96365 (C+), growth factors (G) and growth factors in the 
presence of SK&F96365 (G+). 
Figure 5. Venn diagrams summarising protein overlap between proliferation, morphology 
and assembly and organisation. 182 proteins were uploaded to IPA and based on the 
Ingenuity database mapped to the biological processes. Venn diagram shows an overlap of 
proteins regulated by Ca2+ inhibition and associated with cell proliferation, morphology and 
cellular assembly and organisation. Proteins indicated with      were selected for further 
validation by WB. 
Figure 6. Western blot validation of label-free nLC-MS/MS data. Proteins from cell lysates 
of four treatment conditions C, C+, G, G+ were separated on 1D-gel and then transferred on 
PVDF membrane. Detection of the protein was performed with specific for proteins primary 
antibodies. Figure shows representative Western blot images of three independent 
experiments for [A] paxillin, [C] RAS and [E] CDC42. GAPDH was used as loading control. 
Relative density analysis of the [B] paxillin, [D] RAS and [F] CDC42 protein bands between 
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cell treated with growth factors in the absence (G) and presence of SK&F96365 (G+). GAPDH 
was used as the internal control in relative density analysis. Values are averages from three 
independent experiments. Each value is expressed as mean ± SD. *** p < 0.001, G vs G+ 
group. 
Figure 7. Possible mechanism of CCE dependent regulation of cell cycle in [A] the presence 
and [B] absence of Ca2+ ions.  
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Biological Significance 
The results of this study provide new insight into Ca2+ dependent regulation of cell cycle. 
This manuscript reports first to date global analysis of Ca2+ regulated protein expression 
changes early in G1 in non-transformed human fibroblast cell line. It also highlights 
cannonical signaling pathways and biological processes that are regulated by the inhibition 
of Ca2+ influx. Importantly, it appears that Ca2+ may be the factor that links cell division with 
envirometal cues, cell morphology and cellular assembly and organization, on which cell 
proliferation depends. Hence, the findings presented here provide numerous opportunities 
for more detailed investigations of the mechanism of Ca2+ dependent regulation of cell cycle 
at the molecular and systemic level. 
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